Terazosin Capsule
Product Images NDC 66267-389

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 66267-389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66267 389 30

Care Pharmaceuticals, Inc. produces terazosin 2mg capsules, with the lot number 000000 and the National Drug Code (NDC) 66267-0389-30. These oblong ivory opaque capsules are imprinted with "AP" and "TL34" and contain Terazosin Hydrochloride equivalent to Terazosin 2mg, USP. The expiration date is 00-00. Customers should call their doctor for medical advice about side effects and can report them to the FDA at 1-800-FDA-1088. The product should be stored at a controlled temperature of 68-77°F and kept out of the reach of children.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

This text appears to be a graph or chart that shows changes from a baseline measurement in mL/sec over a period of time, with measurements taken at different intervals (months 0, 1, 2, 3, 6, 12, 15, 18, 21, 24, 27, and 30). Without additional context or information, it is difficult to provide a more detailed description or analysis.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.